Nanostructured Lipid Carriers for Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (10 December 2023) | Viewed by 2319
Special Issue Editors
Interests: natural bioactive compounds; nanotechnologies for drug delivery; biomaterials
Interests: nanotechnology; lipid formulations; drug delivery; drug targeting; cellular models; animal models; oxidative stress; antioxidants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lipid nanoparticles have shown rapid progress and have had an immense impact on the treatment of pathologies such cancer, diabetes, and infections and have also been used in vaccines. Specifically, nanostructured lipid carriers (NLCs) are composed of a mixture of solid and liquid lipids that have been stabilized in the aqueous phase using surfactants. Their biocompatible composition ensures the development of safe drug delivery systems. They are industrially interesting due to their physicochemical stability and scalability. NLCs have attracted increasing amounts of attention in recent years for the delivery of drugs, nucleic acids, proteins, peptides, nutraceuticals, and cosmetics.
This Special Issue aims to highlight recent research on the development of novel NLC-based pharmaceutical formulations to allow readers a holistic overview of the latest progress in the field of nanostructured lipid carriers.
Original research and review articles on the following topics related to NLCs are recommended: the synergistic effects of active ingredients and biomaterials, targeting, controlled release, adsorption/diffusion, and biological and clinical studies.
Dr. Violeta Rodriguez-Ruiz
Dr. Graciela Pavon-Djavid
Dr. Virginie Gueguen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- innovative NLC formulations
- physico-chemical evaluations
- diffusion studies
- preservation of the biological activity: oral administration
- dermal administration
- animal models
- NLC /biomaterial combinations
- biomodelling
- synergistic active ingredients
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.